Darolutamide plus androgen deprivation therapy significantly increased overall survival in men with non-metastatic castration-resistant prostate cancer

NEXT STORY
Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
PREV STORY
mHealth Apps Market to Rise at 21.1% CAGR till 2026; Increasing Number of Novel Products Will Aid Market Growth, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER

Jacques Theurillat to be proposed to Annual Shareholder Meeting for appointment to Board Marc ...

author_avatar
NASDAQ Market News

American Gene Technologies Inc. (AGT) CEO, Jeff Galvin, to Present at HIMSS Precision Medicine Summit

ROCKVILLE, Md., May 31, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), ...

author_avatar
NASDAQ Market News

Global Novel Autism Diagnostics Market 2016 Featuring Asuragen, Google Genomics, Illumina, and LabCorp

Dublin, May 24, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News